BRAND_ANALYSIS #ASTRAZENECA HEALTH & PHARMA #24 OF 26 IN HEALTH & PHARMA ALIGNED

AstraZeneca

· Public · Updated 04 Oct 2026 09:24 UTC
#1026 of 1208 overall by tension · #24 of 26 in Health & Pharma
8 Aligned
The Aligned Power
Analysis

AstraZeneca's 65/73 with 0.60 sentiment and -2.93% stock suggests pharma giants weather volatility through necessity and reputation. Big Pharma's legitimacy crisis hasn't touched execution.

IN THE NEWS (100 articles this week)
AstraZeneca and Daiichi Sankyo announce clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumour types - AstraZeneca
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
Under Pressure – Hypertension and the Heart - AstraZeneca
Cultural Score
65 / 100
Business Score
73 / 100
TENSION▂▂▂▂▁▂▂▂▂▁▂▁▂▁
CULTURAL▅▅▅▄▅▅▅▅▅▅▅▅▄▅
BUSINESS▆▆▆▆▆▆▆▆▆▆▆▅▆▆
Loading...
Wikipedia Momentum 22/40
News Presence 43/35
Search InterestRedistributed to other dimensions
Stock Momentum 16/30
Market Position 22/25
Revenue Growth 19/25
Earnings Health 16/20
Avg Daily (7d)390
Avg Daily (90d)482
7d/90d Ratio0.81x
Price$156.90
30d Change-2.9%
Market Cap$243.3B
Profit Margin17.0%
AstraZeneca's tension is 8. Commerce outpacing culture. sociologyofcapitalism.com/brand/astrazeneca
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/astrazeneca.html" width="320" height="200" frameborder="0"></iframe>